Getting documents signed with pen and paper is hard enough, but doing it while your colleagues and business partners are all working remotely is an even bigger pain. Given the ongoing coronavirus pandemic, it's not a surprise that DocuSign's (NASDAQ: DOCU) flagship e-signature product is signing on more customers than ever. The stock's performance has reflected the tremendous results the company is putting up, and shareholders have realized an incredible threefold return over the last 12 months. But this software-as-a-service specialist isn't anywhere close to done growing yet.
Let's take a closer look at why this is the one stock I'd buy right now.
DocuSign has had a history of amazing growth, more than doubling its top line between fiscal 2017 and fiscal 2020. But the coronavirus has accelerated growth even more.
Source Fool.com